SCHEMBL25716908

SCHEMBL25716908

C=CC(=O)Nc1ccc(-c2c(-c3ccc(Oc4cccc(CCN5CC(CN(C(=O)C=C)c6ccc(-c7c(-c8ccc(Oc9cccc(C)n9)cc8)c8c(N)ncnn8c7OC)cc6)C5)n4)cc3)c3c(N)nccn3c2OC)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 11/20 0.33
▸ PLK4 O00444 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ DAPK3 O43293 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ PAK4 O96013 1/20 0.33
▸ CHEK2 O96017 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ INSR P06213 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ LYN P07948 1/20 0.33
▸ IGF1R P08069 1/20 0.33
▸ MET P08581 1/20 0.33
▸ KIT P10721 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ FGFR1 P11362 1/20 0.33
▸ SRC P12931 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25718208 0.83 BTK (0.35) BTKPLK4AURKADAPK3ROCK2
SCHEMBL25715415 0.80 BTK (0.34) BTKPLK4AURKADAPK3ROCK2
SCHEMBL25718205 0.79 BTK (0.44) BTKEGFRKCNH2TNK2
SCHEMBL25714869 0.79 KDR (0.47) BTKPLK4AURKADAPK3ROCK2
SCHEMBL25715991 0.73 BTK (0.46) BTKEGFRKCNH2TNK2
SCHEMBL30586220 0.72 BTK (0.45) BTKPLK4AURKADAPK3ROCK2
SCHEMBL22676014 0.72 BTK (0.45) BTKPLK4AURKADAPK3ROCK2
SCHEMBL25715529 0.72 FLT3 (0.43) BTKPLK4AURKADAPK3ROCK2
SCHEMBL25714848 0.71 KDR (0.46) BTKPLK4AURKADAPK3ROCK2
SCHEMBL25715613 0.71 KDR (0.45) BTKPLK4AURKADAPK3ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104035-A1 SUBSTITUTED MONOCYCLIC OR BICYCLIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 英矽智能科技(上海)有限公司 2023-06-15 — — WO disclosed
Send feedback